134 related articles for article (PubMed ID: 16517712)
21. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
22. KRN/I-Ag7 mouse arthritis is independent of complement C3.
Tsao PY; Arora V; Ji MQ; Wright AC; Eisenberg RA
J Clin Immunol; 2011 Oct; 31(5):857-63. PubMed ID: 21732014
[TBL] [Abstract][Full Text] [Related]
23. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
24. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
25. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
[TBL] [Abstract][Full Text] [Related]
26. The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation.
Nashar TO; Drake JR
J Immunol; 2005 Feb; 174(3):1306-16. PubMed ID: 15661887
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.
Zhao D; Hajiaghamohseni LM; Liu X; Szulc ZM; Bai A; Bielawska A; Norris JS; Reddy SV; Hannun YA; Haque A
Cytokine; 2020 Nov; 135():155219. PubMed ID: 32738771
[TBL] [Abstract][Full Text] [Related]
29. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
30. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
[TBL] [Abstract][Full Text] [Related]
31. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
Kamradt T; Schubert D
Arthritis Res Ther; 2005; 7(1):20-8. PubMed ID: 15642150
[TBL] [Abstract][Full Text] [Related]
32. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
33. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
Lemos MP; Fan L; Lo D; Laufer TM
J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
[TBL] [Abstract][Full Text] [Related]
34. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
[TBL] [Abstract][Full Text] [Related]
35. Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.
Wilson CL; Hine DW; Pradipta A; Pearson JP; van Eden W; Robinson JH; Knight AM
Immunology; 2012 Apr; 135(4):344-54. PubMed ID: 22182481
[TBL] [Abstract][Full Text] [Related]
36. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.
Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK
J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882
[TBL] [Abstract][Full Text] [Related]
37. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
Turley DM; Miller SD
J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
[TBL] [Abstract][Full Text] [Related]
38. Cell surface heparan sulfate proteoglycans influence MHC class II-restricted antigen presentation.
Léonetti M; Gadzinski A; Moine G
J Immunol; 2010 Oct; 185(7):3847-56. PubMed ID: 20826758
[TBL] [Abstract][Full Text] [Related]
39. Macrophage scavenger receptor 1 (Msr1, SR-A) influences B cell autoimmunity by regulating soluble autoantigen concentration.
Haasken S; Auger JL; Taylor JJ; Hobday PM; Goudy BD; Titcombe PJ; Mueller DL; Binstadt BA
J Immunol; 2013 Aug; 191(3):1055-62. PubMed ID: 23794629
[TBL] [Abstract][Full Text] [Related]
40. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
Dai YD; Marrero IG; Gros P; Zaghouani H; Wicker LS; Sercarz EE
Diabetes; 2009 Jan; 58(1):156-64. PubMed ID: 18984740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
